1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KCNN3 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA ZNF407 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA ARRB1 CTRPv2 pan-cancer AAC -0.17 4e-07
mRNA ZBTB5 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA UBE2G1 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA KATNAL2 CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA E2F5 CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA ANGEL2 CTRPv2 pan-cancer AAC 0.17 8e-07
mRNA TCF3 CTRPv2 pan-cancer AAC 0.2 8e-07
mRNA RAB30 CTRPv2 pan-cancer AAC 0.17 9e-07
Download CSV